Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2646
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    48,121.84
    +14.45 (+0.03%)
     
  • CMC Crypto 200

    1,266.67
    -17.16 (-1.34%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.20 (-0.12%)
     
  • CRUDE OIL

    81.46
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,336.90
    +0.30 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.54 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.14 (+0.01%)
     
  • DAX

    18,235.45
    +24.90 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

Compared to Estimates, Rite Aid (RAD) Q1 Earnings: A Look at Key Metrics

For the quarter ended May 2023, Rite Aid (RAD) reported revenue of $5.65 billion, down 6% over the same period last year. EPS came in at -$0.73, compared to -$0.60 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $5.35 billion, representing a surprise of +5.63%. The company delivered an EPS surprise of +51.01%, with the consensus EPS estimate being -$1.49.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Rite Aid performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Retail Pharmacy - Number of stores: 2284 versus 2387 estimated by two analysts on average.

  • Revenues- Pharmacy Services: $1.20 billion versus the two-analyst average estimate of $1.03 billion.

  • Revenues- Intersegment Eliminations: -$35.32 million versus -$37.39 million estimated by two analysts on average.

View all Key Company Metrics for Rite Aid here>>>

Shares of Rite Aid have returned -15.1% over the past month versus the Zacks S&P 500 composite's +4.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Rite Aid Corporation (RAD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research